Akari Therapeutics names Kameel Farag as interim CFO

Go back to Akari Therapeutics names Kameel Farag as interim CFO
(NASDAQ: AKTX) Delayed: 7.79 -0.11 (1.39%)
Previous Close $7.90    52 Week High $19.75 
Open $8.10    52 Week Low $7.63 
Day High $8.10    P/E N/A 
Day Low $7.69    EPS $0.00 
Volume 16,537